Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 3 | 105 | 5 | 11 | 0 |
| Accounts receivable | -12 | -5 | 4 | 0 | 135 |
| Other Working Capital | -153 | 29 | 98 | -140 | -151 |
| Other Operating Activity | -306 | -351 | 917 | -281 | -484 |
| Operating Cash Flow | $-468 | $-222 | $1,024 | $-411 | $-500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | 0 | 3 |
| Other Investing Activity | 52 | 50 | 52 | 56 | 55 |
| Investing Cash Flow | $52 | $50 | $52 | $56 | $59 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | 0 | -33 | -118 | -145 | -749 |
| Financing Cash Flow | $0 | $-33 | $-118 | $-145 | $-749 |
| Beginning Cash Position | 25,345 | 25,933 | 25,408 | 25,818 | 27,008 |
| End Cash Position | 24,928 | 25,146 | 25,933 | 25,408 | 25,818 |
| Net Cash Flow | $-416 | $-205 | $958 | $-499 | $-1,190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -468 | -222 | 1,024 | -411 | -500 |
| Free Cash Flow | -468 | -222 | 1,024 | -411 | -500 |